Neurotech International Limited (NTI.AX)
AUD 0.03
(-6.67%)
AUD 0.03
(-6.67%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -8.24 Million AUD | 8.18% |
| 2023 | -8.97 Million AUD | -130.05% |
| 2022 | -3.36 Million AUD | 47.36% |
| 2021 | - AUD | -526.27% |
| 2020 | -1.2 Million AUD | 55.35% |
| 2019 | -4.8 Million AUD | 26.52% |
| 2018 | -3.44 Million AUD | 3.77% |
| 2017 | -3.62 Million AUD | -126.01% |
| 2016 | -1.66 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | -4.49 Million AUD | 0.0% |
| 2024 Q2 | -3.93 Million AUD | 0.0% |
| 2024 FY | - AUD | 2.85% |
| 2023 FY | - AUD | -130.05% |
| 2023 Q2 | -4.72 Million AUD | 0.0% |
| 2023 Q4 | -4.29 Million AUD | 0.0% |
| 2022 Q2 | -1.94 Million AUD | 0.0% |
| 2022 FY | - AUD | 47.36% |
| 2022 Q4 | -3.36 Million AUD | 0.0% |
| 2021 FY | - AUD | -526.27% |
| 2021 Q4 | -3.82 Million AUD | 0.0% |
| 2021 Q2 | -3.62 Million AUD | 0.0% |
| 2020 Q4 | -528.01 Thousand AUD | 0.0% |
| 2020 FY | - AUD | 55.35% |
| 2020 Q2 | -660.83 Thousand AUD | 0.0% |
| 2019 Q2 | -1.27 Million AUD | 0.0% |
| 2019 Q4 | -1.4 Million AUD | 0.0% |
| 2019 FY | - AUD | 26.52% |
| 2018 Q4 | -2.07 Million AUD | 0.0% |
| 2018 FY | - AUD | 3.77% |
| 2018 Q2 | -1.54 Million AUD | 0.0% |
| 2017 Q4 | -1.79 Million AUD | 0.0% |
| 2017 Q2 | -1.96 Million AUD | 0.0% |
| 2017 FY | - AUD | -126.01% |
| 2016 Q2 | -523.35 Thousand AUD | -100.0% |
| 2016 Q1 | -261.67 Thousand AUD | 0.0% |
| 2016 Q3 | - AUD | 100.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q4 | -1.75 Million AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| 4DMedical Limited | -36.06 Million AUD | 77.142% |
| Adherium Limited | -11.56 Million AUD | 28.712% |
| Aroa Biosurgery Limited | -7.36 Million AUD | -12.01% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -52.006% |
| Anteris Technologies Ltd | -66.9 Million AUD | 87.678% |
| Control Bionics Limited | -5.15 Million AUD | -59.824% |
| CardieX Limited | -6.71 Million AUD | -22.828% |
| Compumedics Limited | 2.78 Million AUD | 395.591% |
| Cochlear Limited | 579.5 Million AUD | 101.423% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -136.097% |
| Cyclopharm Limited | -3.03 Million AUD | -171.641% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -294.223% |
| Nova Eye Medical Limited | -5.97 Million AUD | -37.883% |
| HeraMED Limited | -3.97 Million AUD | -107.55% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | 62.305% |
| ImpediMed Limited | -22.05 Million AUD | 62.614% |
| InhaleRx Limited | -1.41 Million AUD | -483.135% |
| LBT Innovations Limited | -4.04 Million AUD | -103.607% |
| Micro-X Limited | -14.35 Million AUD | 42.554% |
| OncoSil Medical Limited | -11.97 Million AUD | 31.163% |
| PolyNovo Limited | 5.17 Million AUD | 259.459% |
| Respiri Limited | -7.04 Million AUD | -16.938% |
| SomnoMed Limited | -2.32 Million AUD | -254.032% |
| Universal Biosensors, Inc. | -9.09 Million AUD | 9.311% |
| Uscom Limited | -1.5 Million AUD | -446.212% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -67.65% |